National Bank of Canada FI Purchases Shares of 2,489 Chemed Co. (NYSE:CHE)

National Bank of Canada FI acquired a new position in Chemed Co. (NYSE:CHE) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 2,489 shares of the company’s stock, valued at approximately $1,496,000.

Several other institutional investors have also modified their holdings of the company. Glen Eagle Advisors LLC grew its holdings in Chemed by 57.8% during the third quarter. Glen Eagle Advisors LLC now owns 486 shares of the company’s stock worth $292,000 after acquiring an additional 178 shares during the period. EP Wealth Advisors LLC grew its stake in shares of Chemed by 1.9% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after purchasing an additional 25 shares during the last quarter. State Street Corp raised its holdings in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock worth $279,063,000 after purchasing an additional 3,564 shares in the last quarter. Stifel Financial Corp lifted its stake in Chemed by 1.0% during the third quarter. Stifel Financial Corp now owns 26,996 shares of the company’s stock valued at $16,224,000 after purchasing an additional 273 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new stake in Chemed during the third quarter worth approximately $1,411,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CHE shares. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Chemed Stock Performance

Shares of NYSE:CHE opened at $547.00 on Friday. The firm has a 50 day simple moving average of $570.70 and a 200 day simple moving average of $564.79. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62. The company has a market cap of $8.23 billion, a PE ratio of 27.64, a price-to-earnings-growth ratio of 2.32 and a beta of 0.46.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The business had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the business earned $5.32 EPS. On average, equities analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.37%. Chemed’s dividend payout ratio is 10.11%.

Insider Transactions at Chemed

In other Chemed news, EVP Spencer S. Lee sold 732 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the transaction, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. This represents a 3.85 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,132 shares of company stock valued at $3,003,502 over the last three months. 3.32% of the stock is owned by corporate insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.